📣 VC round data is live. Check it out!
- Public Comps
- Carasent
Carasent Valuation Multiples
Discover Carasent's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Ever Fortune.AI, eWeLL, Kanamic Network, CE Holdings and more.
Carasent Overview
About Carasent
Carasent AB (publ) Formerly Carasent AB is in the businesses that develop entrepreneurial and e-health solutions. It delivers cloud based EHR solutions, with Webdoc as the platform, and a ecosystem of platform services, including solutions for patient communication and business intelligence. The ecosystem of solutions makes Carasent a one-stop shop for clinics and can cover all needs.
Founded
1997
HQ

Employees
165
Website
Financials (LTM)
EV
$151M
Valuation Multiples
Start free trialCarasent Financials
Carasent reported last 12-month revenue of $40M and EBITDA of $9M.
In the same LTM period, Carasent generated $34M in gross profit, $9M in EBITDA, and $4M in net income.
Revenue (LTM)
Carasent P&L
In the most recent fiscal year, Carasent reported revenue of $39M and EBITDA of $10M.
Carasent is profitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 27%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Carasent Stock Performance
Carasent has current market cap of $162M, and enterprise value of $151M.
Market Cap Evolution
Carasent's stock price is $2.43.
Carasent share price decreased by 4.5% in the last 30 days, and by 24.4% in the last year.
Carasent has an EPS (earnings per share) of $0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $151M | $162M | -3.7% | -4.5% | -3.2% | -24.4% | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCarasent Valuation Multiples
Carasent trades at 3.8x EV/Revenue multiple, and 16.5x EV/EBITDA.
EV / Revenue (LTM)
Carasent Financial Valuation Multiples
As of June 3, 2026, Carasent has market cap of $162M and EV of $151M.
Carasent has a P/E ratio of 44.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Carasent Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Carasent Margins & Growth Rates
Carasent grew revenue by 10% and EBITDA by 1% in the last fiscal year.
In the most recent fiscal year, Carasent reported gross margin of 80%, EBITDA margin of 27%, and net margin of 10%.
Carasent Margins
Carasent Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Carasent Operational KPIs
Carasent's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Carasent's Rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carasent's Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Carasent Competitors
Carasent competitors include Ever Fortune.AI, eWeLL, Kanamic Network, CE Holdings, Kusurinomadoguchi, Nano X Imaging, Airdoc, MTI Ltd., Fonet and Findex.
Most Carasent public comparables operate across Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 12.2x | - | 31.1x | - | |||
| 7.4x | 6.8x | 15.2x | 13.9x | |||
| 3.6x | 3.4x | 9.8x | 9.5x | |||
| 1.4x | 1.4x | 8.2x | - | |||
| 2.4x | 2.1x | 9.0x | 6.7x | |||
| 6.3x | 4.0x | (1.7x) | - | |||
| 1.6x | 1.6x | (41.9x) | - | |||
| 0.6x | 0.6x | 2.9x | 3.7x | |||
This data is available for Pro users. Sign up to see all Carasent competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Carasent
Carasent has acquired 5 companies to date.
Last acquisition by Carasent was on April 26th 2026. Carasent acquired InfoSolutions Sverige for $12M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Carasent
| Description | InfoSolutions Sverige AB is a Swedish provider of services and products that manage information exchange between healthcare systems. | HPI Health Profile Institute AB is a Swedish developer of health assessment methods and software. Stockholm-based, it provides tools for wellness profiling, education programs, and research in preventive healthcare. The institute supports corporations and healthcare providers with digital platforms tracking employee health metrics. | - | Metodika is a software suite designed for healthcare practice management. It automates scheduling, task workflows, patient records, and billing processes while providing analytics for clinic performance. Targeted at medical offices, the platform connects daily operations to streamline administrative duties and support operational improvements. | |
| HQ Country | |||||
| HQ City | Stockholm | Stockholm | - | Stockholm | |
| Deal Date | 26 Apr 2026 | 18 Oct 2022 | 15 Dec 2021 | 26 May 2021 | |
| Valuation | $12M | $3M | $12M | $10M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Carasent acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Carasent
| When was Carasent founded? | Carasent was founded in 1997. |
| Where is Carasent headquartered? | Carasent is headquartered in Norway. |
| How many employees does Carasent have? | As of today, Carasent has over 165 employees. |
| Who is the CEO of Carasent? | Carasent's CEO is Daniel Ohman. |
| Is Carasent publicly listed? | Yes, Carasent is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Carasent? | Carasent trades under CARA ticker. |
| When did Carasent go public? | Carasent went public in 2012. |
| Who are competitors of Carasent? | Carasent main competitors include Ever Fortune.AI, eWeLL, Kanamic Network, CE Holdings, Kusurinomadoguchi, Nano X Imaging, Airdoc, MTI Ltd., Fonet, Findex. |
| What is the current market cap of Carasent? | Carasent's current market cap is $162M. |
| What is the current revenue of Carasent? | Carasent's last 12 months revenue is $40M. |
| What is the current revenue growth of Carasent? | Carasent revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Carasent? | Current revenue multiple of Carasent is 3.8x. |
| What is the current EBITDA of Carasent? | Carasent's last 12 months EBITDA is $9M. |
| What is Carasent's EBITDA margin? | Carasent's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Carasent? | Current EBITDA multiple of Carasent is 16.5x. |
| What is the current FCF of Carasent? | Carasent's last 12 months FCF is $2M. |
| What is Carasent's FCF margin? | Carasent's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Carasent? | Current FCF multiple of Carasent is 72.1x. |
| How many companies Carasent has acquired to date? | As of June 2026, Carasent has acquired 5 companies. |
| What was the largest acquisition by Carasent? | $12M acquisition of InfoSolutions Sverige on 26th April 2026 was the largest M&A Carasent has done to date. |
| What companies Carasent acquired? | Carasent acquired InfoSolutions Sverige, Avans Soma, Medrave, Metodika, and HPI Health Profile Institute AB. |
| In how many companies Carasent has invested to date? | Carasent hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Carasent
Lists including Carasent
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
